“We engaged IP Pragmatics to help us negotiate an IP licensing agreement with a leading UK University. We were very impressed by their extensive experience and responsiveness from the start. They have lived up to our expectation, helping us take a very hard negotiation over the line. We enjoyed working with them and would do so again. I would definitely recommend them to organisations trying to navigate IP licensing negotiations.”
CEO, Biotip Ltd
“With an understanding of what I was seeking to learn, IP Pragmatics provided a clear scope and planned deliverables to align us on the intended market and IP research. In a small number of weeks my company was able to greatly increase our intelligence in a new market and inform our strategy going forward. I found my interactions with IP Pragmatics to be some of the best I have had in my 30+ years in the business, great listening, clear objective setting, and regularly held phone conferences to stay in touch along the path helped us both achieve a successful end result. The final outcome exceeded my expectations and I would highly recommend others consider IP Pragmatics as a partner in their programs.”
Global New Ventures R&D Executive, US Multinational consumer products company
“IP Pragmatics has performed a number of market assessments for early stage technologies emerging from the University. We have been very impressed by their ability to quickly grasp novel technologies spanning a range of disciplines, and frame these in a commercial context. The company’s in-depth biopharma and life sciences market knowledge, IP expertise, industry networks and high-quality reporting have been crucial in helping the University research teams progress their technologies in line with the most promising commercial opportunities.”
IP & Commercialisation team, Innovation & Industry Engagement Directorate, University of Strathclyde
“IP Pragmatics are a pleasure to work with and the primary market research has in particular supported delivering impact by identifying routes to take a project forward through finding research collaborators, potential licensees and in some cases their work has helped to build a case to support company formation.”
Senior Licensing & Ventures Manager
“The market analysis work undertaken by IP Pragmatics was approached with professionalism and high degree of knowledge. The commitment to due diligence and engagement with the project helped allow it to succeed beyond expectations.”
University of Oxford
The Microbiome Market 2021: Recent Developments, Challenges and Future Directions
IP Pragmatics first released a white paper on the microbiome market in 2017, when the academic, commercial and patenting trends reflected an industry which was at an early stage but was undergoing extraordinary growth. Since 2017 there has been vertical and horizontal growth in the microbiome market, evolving technological capabilities and an increasingly diverse landscape of start-up formation, partnerships and deal-making, which we have aimed to capture in our new 2021 white paper.
